AzTrials
AzTrials

HealthyStratiPolNCT03573414

Gut Microbial Metabolism of Polyphenols and Cardiovascular Health (StratiPol) (Stratification Study)

A study testing raspberry powder, milled flaxseed and soy milk in people with Healthy, run by King's College London at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

There is increasing interest in the effects of various food derived polyphenols on cardiovascular health. Several studies have demonstrated improvements in vascular function after intake of polyphenol rich foods. Read more about this study

Who is it for?
Ages 20 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
raspberry powder, milled flaxseed and soy milk
Could I receive a placebo?
No, everyone receives an active treatment
How many people
250 participants
Where
1 siteUnited Kingdom
Study dates
2 Jul 2018to Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy men and women aged 20-70 years
  • BMI between 18.5 and 35 kg/m2
  • Subjects are willing to maintain their normal eating/drinking habits and exercise habits to avoid changes in body weight over the duration of the study
  • Are able to understand the nature of the study
  • Able to give signed written informed consent
  • Signed informed consent form

Who cannot join

  • Medical history of cardiovascular disease including coronary artery disease, cerebrovascular disease and peripheral artery disease
  • Hypertensive, defined as 140/90mmHg or higher
  • Obese participants with BMI superior or equal to 35 kg/m2
  • Underweight participants defined by a BMI inferior to 18.5 kg/m2
  • Medical history of diabetes mellitus, metabolic syndrome, terminal renal failure or malignancies
  • Abnormal heart rhythm (lower or higher than 60-100 bpm)
Show all 13Show fewer
  • Allergies to berries or other significant food allergy
  • Subjects under medication that can affect the cardiovascular system or on vitamin/dietary supplements.
  • Subjects who have lost more than 10% of their weight in the past 6 months or are currently in a diet
  • Subjects who reported participant in another study within one month before the study start
  • Subjects who smoke an irregular amount of cigarettes per day
  • Pregnant women or planning to become pregnant in the next 6 months
  • Any reason or condition that in the judgment of the clinical investigator(s) may put the subject at unacceptable risk or that may preclude the subject from understanding or complying with the study's requirements.

Trial locations and contacts

1 site in 1 country.

Julia Casani-Cubel, MBBS contact

+44 (0) 20 7848 4162

julia.casani@kcl.ac.uk

Paul YOUNG TIE YANG, MSc contact

02078484162

paul.young_tie_yang@kcl.ac.uk

United Kingdom1 site, 1 recruiting
  • King's College London, Department of Nutritional Sciences

    London, SE1 9NH

    Dr. Ana Rodriguez-mateos, PhD, ana.rodriguez-mateos@kcl.ac.uk

    Recruiting

Other trials in United Kingdom

About this study

Official title: Gut Microbial Metabolism of Polyphenols and Cardiovascular Health

There is increasing interest in the effects of various food derived polyphenols on cardiovascular health. Several studies have demonstrated improvements in vascular function after intake of polyphenol rich foods. The objective of this study is to investigate the association between polyphenol microbiota metabolism and cardiovascular health.

The participants (n=250) with age range between 20 to 70 years old health overweight men and women. The participants will consume a polyphenol rich breakfast for three days (consisting on milled flaxseed, raspberry powder and soy milk). The participants will provide the investigators with urine and blood samples for polyphenol analysis. Cardiovascular measurements such as PWV, AIx, Blood Pressure and FMD will be performed at baseline and after 72h.

Conditions
Healthy
Being tested
raspberry powder, milled flaxseed and soy milk
Keywords
Cardiovascular system, Polyphenols

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • raspberry powder, milled flaxseed and soy milkOther

    • The participants will consume a breakfast consisting of 30 g of milled flaxseed, 40 g of raspberry powder and 250 ml of soy milk for 3 days
    • The participants will provide blood and urine samples
Study groups in NCT03573414
Study groupRoleWhat they receive
Healthy men and womenExperimentalIntervention: 2*breakfast containing 40 g of raspberry powder, 30 g milled flax seeds and 250 mL of soy Milk.
Receives: Other: raspberry powder, milled flaxseed and soy milk

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Plasma and 24 h urine gut microbial polyphenol metabolites after high polyphenol breakfast.

    To examine ellagitannins, lignans and isoflavones metabolites levels in urine and plasma assessed by liquid chromatography - mass spectrometer (LCMS) post 3 days consumption of high polyphenol breakfast contain 40 g raspberry powder, 30 g milled flaxseed and 250 mL soy milk to establish metabotypes.

    Measured: 1-3 days

Secondary outcomes (6)
  1. Changes in flow- mediated dilation after 3 days consumption of high polyphenol breakfast.

    Determine the effect post 3 day consumption of a polyphenol rich breakfast containing raspberry ellagitannins, flaxseed lignans and soy milk isoflavones on endothelium-dependent flow mediated dilation (FMD) of the brachial artery, including diameter and flow velocity using Ultra sound device.

    Measured: Baseline 0 and 72 hours.

  2. Changes in Pulse Wave Velocity (PWV) after 3 days consumption of high polyphenol. breakfast

    Determine the effect post 3 days of consumption of a polyphenol rich breakfast containing raspberry ellagitannins, flaxseed lignans and soy milk isoflavones on arterial stiffness measured as pulse wave velocity (PWV) using a Sphygmocor device.

    Measured: Baseline 0 and 72 hours.

  3. Changes in augmentation Index (AIx) after 3 days consumption of high polyphenol breakfast.

    Determine the effect post 3 days of consumption of a polyphenol rich breakfast containing raspberry ellagitannins, flaxseed lignans and soy milk isoflavones on arterial stiffness measured Augmentation index ( AIX) using a Sphygmocor device.

    Measured: Baseline 0 and 72 hours.

  4. Changes in office Blood pressure after 3 days consumption of high polyphenol breakfast.

    Determine the effect post 3 days of consumption of a polyphenol rich breakfast containing raspberry ellagitannins, flaxseed lignans and soy milk isoflavones on central and peripheral systolic and diastolic blood pressure.

    Measured: Baseline 0 and 72 hours.

  5. Changes in heart rate after 3 days consumption of high polyphenol breakfast.

    Determine the effect post 3 days of consumption of a polyphenol rich breakfast containing raspberry ellagitannins, flaxseed lignans and soy milk isoflavones on heart rate.

    Measured: Baseline 0 and 72 hours.

  6. Plasma and Urine polyphenol metabolites levels for ellagitannins, lignans and isoflavones.

    Determine the bioavailability of polyphenols post 3 days of consumption of a polyphenol rich breakfast in blood and urine samples measured by liquid chromatograph - mass spectrometry (LCMS)

    Measured: Baseline 0 and 72 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2018
  2. Study start2 Jul 2018
  3. Primary completionSep 2022 (estimated)
  4. Study completionSep 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03573414
Sponsor's protocol ID
Stratification Study
Acronym
StratiPol
Status last verified
Mar 2022
First submitted
1 Jun 2018
Last updated
31 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing raspberry powder, milled flaxseed and soy milk in people with Healthy, run by King's College London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Julia Casani-Cubel, MBBS (+44 (0) 20 7848 4162, julia.casani@kcl.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Plasma and 24 h urine gut microbial polyphenol metabolites after high polyphenol breakfast. (time frame: 1-3 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in